Category

UF Innovate | Accelerate @ Sid Martin Biotech

CITI Program and Biotility at UF Announce Partnership

The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility’s biotech training courses on CITI Program’s learning platform.

Florida Institute and MPWRM Resource Center Fund Amend Surgical

UF Innovate | Sid Martin Biotech alum Amend Surgical, Inc., an Alachua-based medical device company, announced that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology (the Florida Institute) along with being awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center.

Surgalign Appoints David Lyle As Chief Financial Officer

Surgalign Holdings, a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced the appointment of David Lyle, as Chief Financial Officer, effective immediately. Surgalign acquired UF startup and Sid Martin Biotech alum RTI Surgical in 2020.

Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load

Tests with lab animals show a vaccine given as a nasal spray produces high antibody volumes against SARS-CoV-2 infections and reduces viral loads. Results of tests by biotechnology companies Oragenics Inc., a Sid Martin Biotech alum located in Tampa, and Inspirevax in Laval, Quebec, with National Research Council of Canada, appear on the bioRxiv pre-publication server, and are not yet peer-reviewed.